>Since it is pretty invasive I don't know how many would rush to get it but the results seemed promising.<
The "deep brain simulation" mentioned in the article involves placing electrodes in the brain and keeping them there, which is pretty invasive too but works quite well for some Parkinson's patients. http://www.medtronic.com/neuro/parkinsons/activa_qa.html
PD may be a good target for gene therapy because a relatively small portion of the brain is involved, so you don't have to worry about slow diffusion rates keeping the viral vector from carrying the gene where it needs to go.
Still, this is a small trial run by a tiny company. It's too early to tell if it works well or if the company can find the money to run larger trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.